Oncology Data Advisor

Harnessing Precision Medicine in Oncology With Ofer Sharon, MD

Informações:

Synopsis

In this interview, Ofer Sharon, MD, the CEO of OncoHost, explains the unique opportunities for harnessing precision medicine in oncology, the unmet needs regarding biomarker development, and the potential of utilizing a multicomponent biomarker approach for understanding the mechanisms of therapy resistance and developing novel pathways for treatment.